trending Market Intelligence /marketintelligence/en/news-insights/trending/_zkW2_dI6q0vFs6vIMCTuw2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Synergy Pharmaceuticals prices $125M common stock offering


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


COVID-19 Impact & Recovery: Investment Banking

Synergy Pharmaceuticals prices $125M common stock offering

Synergy Pharmaceuticals Inc. priced a previously announced underwritten offering of shares at $6.15 apiece.

The company will issue 20,325,204 shares with closing expected by Feb. 6.

Cantor Fitzgerald & Co. and Canaccord Genuity Inc. are acting as joint book-running managers of the issue while H.C. Wainwright & Co. LLC is serving as co-manager.

Synergy plans to use amounts raised to fund the commercialization of Trulance while advancing the clinical development of Plecanatide, among other things.